Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07573592Not ApplicableCompleted

Clinical Evaluation of an Atopic Skin Product Containing Picea Abies Resin Extract

Role: collaborator

NCT06545552Not ApplicableCompleted

Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen Effluvium

Role: collaborator

NCT05057351Not ApplicableCompleted

A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis

Role: collaborator

NCT04912947Not ApplicableCompleted

EValuation of the Antioxidant and Anti-inflammatory Capacity of Nutraceutical IMMU·SYSTEM Food Supplement (EVAANIS)

Role: lead

NCT04884347Not ApplicableCompleted

Evaluation of the Efficacy of a Food Supplement in Reducing Hair Loss in Male Subjects

Role: collaborator

All 5 trials loaded